中国2018-2019年风疹流行病学特征Epidemiology of rubella in China, 2018-2019
李媛秋,马超,郝利新,王富珍,温宁,杨宏,唐林,安志杰,尹遵栋
摘要(Abstract)：
目的分析中国2018-2019年风疹流行病学特征。方法利用全国麻疹/风疹监测信息报告管理系统收集中国2018-2019年风疹发病数据,描述性分析风疹发病特征。结果中国2018年、2019年分别报告风疹3 930例(0.28/10万)、32 539例(2.33/10万)。2018年10-19岁、20-29岁病例分别占45.12%、29.87%,2019年分别占68.98%、18.79%。2018年10-19岁、≥20岁病例中无或不详风疹免疫史分别占91.67%、98.49%,2019年分别占93.77%、98.41%。结论中国2018-2019年风疹发病水平持续上升,无风疹免疫史的10-29岁人群发病风险高;建议开展中学生风疹补充免疫工作。
关键词(KeyWords)： 风疹;流行病学
基金项目(Foundation): 中国CDC公共卫生应急反应机制的运行(131031001000150001)
作者(Author): 李媛秋,马超,郝利新,王富珍,温宁,杨宏,唐林,安志杰,尹遵栋
参考文献(References)：
- [1] LAMBERT N,STREBEL P,ORENSTEIN W,et al.Rubella [J].The Lancet,2015,385:2297-2307.
- [2] CUTTS FT,VYNNYCKY E.Modelling the incidence of congenital rubella syndrome in developing countries[J].International Journal of Epidemiology,1999,28(6):1176-1184.
- [3] SU Q,MA C,WEN N,et al.Epidemiological profile and progress toward rubella elimination in China.10 years after nationwide introduction of rubella vaccine[J].Vaccine,2018,36(16):2079-2085.
- [4] ZHU Z,EMILY A,CUI A,et al.Rubella virus genotypes in the People's Republic of China between 1979 and 2007:a shift in endemic viruses during the 2001 rubella epidemic[J].Journal of Clinical Microbiology,2010,48(5):1775-1781.
- [5] World Health Organization.Distribution of rubella cases by country and by month,2015-2019[EB/OL].[2020-08-01].https://www.who.int/immunization/monitoring_surveillance/burden/vpd/surveillance_type/active/measles_monthlydata/en/.
- [6] World Health Organization.Global and regional immunization profile[EB/OL].[2020-08-04].https://www.who.int/immunization/monitoring_surveillance/data/en/.
- [7] HIDETOSHI N,MASAHIRO I,TAKATO N,et al.Conjunctivitis,the key clinical characteristic of adult rubella in Japan during two large outbreaks,2012-2013 and 2018-2019[J].PLoS One,2020,15(4):0231966.
- [8] HE H,YAN R,TANG X,et al.Vaccination in secondary school students expedites rubella control and prevents congenital rubella syndrome[J].BMC Infectious Diseases,2016,16(1):723.
- [9] 佚名.关于国家免疫规划脊髓灰质炎疫苗和含麻疹成分疫苗免疫程序调整相关工作的通知[J].中华人民共和国国家卫生健康委员会公报,2019,(12):25-26.
- [10] Ministry of Health,Labour and Walfare.Promotion of rubella antibody test implementation in workplace health check-up [EB/OL].[2020-10-10].https://www.mhlw.go.jp/stf/newpage_09247.html
- [11] ZHOU Q,WANG Q,SHEN H,et al.Rubella virus immunization status in preconception period among Chinese women of reproductive age:a nation-wide,cross-sectional study[J].Vaccine,2017,35(23):3076-3081.
- [12] KNAPP JK,MARIANO KM,PASTORE R,et al.Progress toward rubella elimination - Western Pacific Region,2000-2019[J].Morbidity and Mortality Weekly Report,2020,69(24):744-750.
- [13] World Health Organization Regional Office for the Western Pacific.Eighth Annual Meeting of the Regional Verification Commission for Measles and Rubella Elimination in the Western Pacific Region[EB/OL].[2020-08-04].https://iris.wpro.who.int/handle/10665.1/14458.
- [14] 孟丽,崔智多,汪滢,等.齐齐哈尔市先天性风疹综合征监测分析[J].中国社区医师(医学专业),2013,15(6):366-367.
- [15] World Health Organization Regional Office for the Western Pacific.WPR/RC68.R1:measles and rubella elimination (resolution)[EB/OL].[2020-09-05].https://iris.wpro.who.int/handle/10665.1/13717.